Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29

Claudio Gasperini, Raymond Hupperts, Jan Lycke, Christine Short, Manjit McNeill, John Zhong, Lahar R. Mehta

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)123-131
JournalJournal of the Neurological Sciences
Volume370
DOIs
Publication statusPublished - 15 Nov 2016

Keywords

  • MSIS-29
  • Prolonged-release fampridine
  • Multiple sclerosis
  • MSWS-12
  • Patient-reported outcomes
  • Walking impairment

Cite this